Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 54Neoplasms 38Lung Neoplasms 24Colorectal Neoplasms 24Prostatic Neoplasms 17Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Pancreatic Neoplasms 9Hematologic Neoplasms 9Anxiety Disorders 9Urinary Bladder Neoplasms 8Obesity 8Melanoma 8Lymphoma 8Depression 8Ovarian Neoplasms 7Endometrial Neoplasms 7Vulvar Neoplasms 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Sarcoma 5Papillomavirus Infections 5Pain 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4

Interventions

Tea 1Surveys and Questionnaires 1Propofol 1Midazolam 1Methods 1Fluorodeoxyglucose F18 1Fentanyl 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Respiration Disorders × Methods × Clear all
NCT03750110 2022-05-19

YESS

University of Nottingham

Phase NA Completed
1,001 enrolled
Thoracic

Heart Diseases, Lung Neoplasms, Respiration Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡